Expression of galectin-3 in gonads and gonadal sex cord stromal and germ cell tumors

Oncology Reports

Volumn 16, Issue 2, 2006, Pages 335-340

  Devouassoux Shisheboran, Mojgan ^a,b   Deschildre, Catherine ^a   Mauduit, Claire ^a   Berger, Gérard ^c   Mejean Lebreton, Fréd́erique ^b   Bouvier, Raymonde ^c   Droz, Jean Pierre ^a   Fénichel, Patrick ^d   Benahmed, Mohamed ^a  

^a INSERM   (France)

^b CROIX ROUSSE HOSPITAL   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

Galectin; Galectin 3; Germ cell tumors; Lectins; Sex cord tumors; Testis

Indexed keywords

ANDROGEN RECEPTOR; GALECTIN 3; MESSENGER RNA; TUMOR MARKER;

ARTICLE; CHEMISTRY; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; OVARY; OVARY TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERTOLI CELL; SERTOLI CELL TUMOR; SEX CORD TUMOR; TESTIS; TESTIS TUMOR;

FEMALE; GALECTIN 3; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; OVARIAN NEOPLASMS; OVARY; RECEPTORS, ANDROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERTOLI CELL TUMOR; SERTOLI CELLS; SEX CORD-GONADAL STROMAL TUMORS; TESTICULAR NEOPLASMS; TESTIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33748543241     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.16.2.335     Document Type: Article

References (21)

1. Krzeslak A and Lipinska A: Galectin-3 as a multifunctional protein. Cell Mol Biol Lett 9: 305-328, 2004. (Pubitemid 38902225)
2. Xu XC, el-Naggar AK and Lotan R: Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications. Am J Pathol 147: 815-822, 1995.
3. Berberat PO, Friess H, Wang L, Zhu Z, Bley T, Frigeri L, Zimmermann A and Buchler MW: Comparative analysis of galectins in primary tumors and tumor metastasis in human pancreatic cancer. J Histochem Cytochem 49: 539-549, 2001. (Pubitemid 32295176)
4. Song YK, Billiar TR and Lee YJ: Role of galectin-3 in breast cancer metastasis: involvement of nitric oxide. Am J Pathol 160: 1069-1075, 2002. (Pubitemid 34224593)
5. Wollina U, Schreiber G, Gornig M, Feldrappe S, Burchert M and Gabius HJ: Sertoli cell expression of galectin-1 and -3 and accessible binding sites in normal human testis and Sertoli cell only-syndrome. Histol Histopathol 14: 779-784, 1999. (Pubitemid 29320342)
6. Kayser K, Hoeft D, Hufnagi P, Caselitz J, Zick Y, Andre S, Kaltner H and Gabius HJ: Combined analysis of tumor growth pattern and expression of endogenous lectins as a prognostic tool in primary testicular cancer and its lung metastases. Histol Histopathol 18: 771-779, 2003. (Pubitemid 36773222)
7. Young RH: Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems. Mod Pathol 18 (suppl 2): 81-98, 2005.
8. Kinugawa K, Hyodo F, Matsuki T, Jo Y, Furukawa Y, Ueki A and Tanaka H: Establishment and characterization of a new human testicular seminoma cell line, JKT-1. Int J Urol 5: 282-287, 1998. (Pubitemid 28302460)
9. Andjilani M, Droz JP, Benahmed M and Tabone E: alpha6 integrin subunit mediates laminin enhancement of cisplatin-induced apoptosis in testicular tumor germ cells. Int J Cancer 117: 68-81, 2005. (Pubitemid 41262761)
10. Bozec A, Ruffion A, Decaussin M, Andre J, Devonec M, Benahmed M and Mauduit C: Activation of caspases-3, -6, and -9 during finasteride treatment of benign prostatic hyperplasia. J Clin Endocrinol Metab 90: 17-25, 2005. (Pubitemid 40116628)
11. Kreuzer KA, Lassu U, Landt O, et al : Highly sensitive and specific fluorescence reverse transcription-PCR assay for the pseudogene-free detection of beta-actin transcripts as quantitative reference. Clin Chem 45: 297-300, 1999. (Pubitemid 29079135)
12. Fowlis D, Colnot C, Ripoche MA and Poirier F: Galectin-3 is expressed in the notochord, developing bones, and skin of the postimplantation mouse embryo. Dev Dyn 203: 241-251, 1995.
13. Van den Brule FA, Engel J, Stetler-Stevenson WG, Liu FT, Sobel ME and Castronovo V: Genes involved in tumor invasion and metastasis are differentially modulated by estradiol and progestin in human breast-cancer cells. Int J Cancer 52: 653-657, 1992.
14. Chiariotti L, Salvatore P, Frunzio R and Bruni CB: Galectin genes: regulation of expression. Glycoconj J 19: 441-449, 2004. (Pubitemid 38316517)
15. Honjo Y, Nangia-Makker P, Inohara H and Raz A: Downregulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells. Clin Cancer Res 7: 661-668, 2001. (Pubitemid 32707992)
16. Van den Brule FA, Berchuck A, Bast RC, Liu FT, Gillet C, Sobel ME and Castronovo V: Differential expression of the 67-kD laminin receptor and 31-kD human laminin-binding protein in human ovarian carcinomas. Eur J Cancer 30A: 1096-1099, 1994. (Pubitemid 24277834)
17. Pacis RA, Pilat MJ, Pienta KJ, Wojno K, Raz A, Hogan V and Cooper CR: Decreased galectin-3 expression in prostate cancer. Prostate 44: 118-123, 2000. (Pubitemid 30419186)
18. Gabius HJ, Engelhardt R, Casper J, Schmoll HJ, Nagel GA and Cramer F: Comparison of endogenous lectins in human embryonic carcinoma and yolk sac carcinoma. Tumour Biol 6: 471-482, 1986. (Pubitemid 17010497)
19. Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, Khan A, Inohara H, Marandino F, Orlandi F, Nardi F, Vecchione A, Tecce R and Larsson O: Thyroid Cancer Study Group. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 357: 1644-1650, 2001. (Pubitemid 32568236)
20. Matarrese P, Tinari N, Semeraro ML, Natoli C, Iacobelli S and Malorni W: Galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis. FEBS Lett 473: 311-315, 2000. (Pubitemid 30249145)
21. Oka N, Nakahara S, Takenaka Y, et al: Galectin-3 inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by activating Akt in human bladder carcinoma cells. Cancer Res 65: 7546-7553, 2005. (Pubitemid 41297223)